Literature DB >> 28712309

Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors.

Elena Herrera-Carrillo1, Ying Poi Liu1, Ben Berkhout1.   

Abstract

The RNA interference pathway is an evolutionary conserved post-transcriptional gene regulation mechanism that is exclusively triggered by double-stranded RNA inducers. RNAi-based methods and technologies have facilitated the discovery of many basic science findings and spurred the development of novel RNA therapeutics. Transient induction of RNAi via transfection of synthetic small interfering RNAs can trigger the selective knockdown of a target mRNA. For durable silencing of gene expression, either artificial short hairpin RNA or microRNA encoding transgene constructs were developed. These miRNAs are based on the molecules that induce the natural RNAi pathway in mammals and humans: the endogenously expressed miRNAs. Significant efforts focused on the construction and delivery of miRNA cassettes in order to solve basic biology questions or to design new therapy strategies. Several viral vectors have been developed, which are particularly useful for the delivery of miRNA expression cassettes to specific target cells. Each vector system has its own unique set of distinct properties. Thus, depending on the specific application, a particular vector may be most suitable. This field was previously reviewed for different viral vector systems, and now the recent progress in the field of miRNA-based gene-silencing approaches using lentiviral vectors is reported. The focus is on the unique properties and respective limitations of the available vector systems for miRNA delivery.

Entities:  

Keywords:  gene therapy; miRNA cassettes; vector tropism; viral vectors

Mesh:

Substances:

Year:  2017        PMID: 28712309      PMCID: PMC5568016          DOI: 10.1089/hgtb.2017.036

Source DB:  PubMed          Journal:  Hum Gene Ther Methods        ISSN: 1946-6536            Impact factor:   2.396


  209 in total

1.  Induction of an interferon response by RNAi vectors in mammalian cells.

Authors:  Alan J Bridge; Stephanie Pebernard; Annick Ducraux; Anne-Laure Nicoulaz; Richard Iggo
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

2.  A facile method to increase titers of miRNA-encoding retroviruses by inhibition of the RNaseIII enzyme Drosha.

Authors:  Andreas Brandl; Jürgen Wittmann; Hans-Martin Jäck
Journal:  Eur J Immunol       Date:  2010-12-29       Impact factor: 5.532

3.  Construction and molecular analysis of gene transfer systems derived from bovine immunodeficiency virus.

Authors:  R Berkowitz; H Ilves; W Y Lin; K Eckert; A Coward; S Tamaki; G Veres; I Plavec
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice.

Authors:  Ciaran D Scallan; Haiyan Jiang; Tongyao Liu; Susannah Patarroyo-White; Jurg M Sommer; Shangzhen Zhou; Linda B Couto; Glenn F Pierce
Journal:  Blood       Date:  2005-10-25       Impact factor: 22.113

5.  siRNA-mediated gene silencing in vitro and in vivo.

Authors:  Haibin Xia; Qinwen Mao; Henry L Paulson; Beverly L Davidson
Journal:  Nat Biotechnol       Date:  2002-09-16       Impact factor: 54.908

6.  Adeno-associated virus vectors integrate at chromosome breakage sites.

Authors:  Daniel G Miller; Lisa M Petek; David W Russell
Journal:  Nat Genet       Date:  2004-06-20       Impact factor: 38.330

7.  Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients.

Authors:  Rafael G Amado; Ronald T Mitsuyasu; Joseph D Rosenblatt; Frances K Ngok; Andreas Bakker; Steve Cole; Nathalie Chorn; Lii-Shin Lin; Gregory Bristol; Maureen P Boyd; Janet L MacPherson; Gregory C Fanning; Alison V Todd; Julie A Ely; Jerome A Zack; Geoff P Symonds
Journal:  Hum Gene Ther       Date:  2004-03       Impact factor: 5.695

8.  Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial.

Authors:  Nicola G Ghazi; Emad B Abboud; Sawsan R Nowilaty; Hisham Alkuraya; Abdulrahman Alhommadi; Huimin Cai; Rui Hou; Wen-Tao Deng; Sanford L Boye; Abdulrahman Almaghamsi; Fahad Al Saikhan; Hassan Al-Dhibi; David Birch; Christopher Chung; Dilek Colak; Matthew M LaVail; Douglas Vollrath; Kirsten Erger; Wenqiu Wang; Thomas Conlon; Kang Zhang; William Hauswirth; Fowzan S Alkuraya
Journal:  Hum Genet       Date:  2016-01-29       Impact factor: 4.132

9.  Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration.

Authors:  Eugenio Montini; Daniela Cesana; Manfred Schmidt; Francesca Sanvito; Maurilio Ponzoni; Cynthia Bartholomae; Lucia Sergi Sergi; Fabrizio Benedicenti; Alessandro Ambrosi; Clelia Di Serio; Claudio Doglioni; Christof von Kalle; Luigi Naldini
Journal:  Nat Biotechnol       Date:  2006-05-28       Impact factor: 54.908

10.  HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome.

Authors:  Ellen M Westerhout; Marcel Ooms; Monique Vink; Atze T Das; Ben Berkhout
Journal:  Nucleic Acids Res       Date:  2005-02-01       Impact factor: 16.971

View more
  17 in total

Review 1.  Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA.

Authors:  Tandrima Mitra; Selvakumar Elangovan
Journal:  Mol Cell Biochem       Date:  2021-08-28       Impact factor: 3.396

Review 2.  MicroRNAs as therapeutic targets in breast cancer metastasis.

Authors:  Fahima Danesh Pouya; Yousef Rasmi; Maria Gazouli; Eleni Zografos; Mohadeseh Nemati
Journal:  Drug Deliv Transl Res       Date:  2021-05-13       Impact factor: 4.617

Review 3.  Role of MicroRNAs in Renal Parenchymal Diseases-A New Dimension.

Authors:  Saeed Kamran Shaffi; David Galas; Alton Etheridge; Christos Argyropoulos
Journal:  Int J Mol Sci       Date:  2018-06-17       Impact factor: 5.923

Review 4.  The Regulatory Role of MicroRNAs in Breast Cancer.

Authors:  Hui-Yi Loh; Brendan P Norman; Kok-Song Lai; Nik Mohd Afizan Nik Abd Rahman; Noorjahan Banu Mohamed Alitheen; Mohd Azuraidi Osman
Journal:  Int J Mol Sci       Date:  2019-10-06       Impact factor: 5.923

5.  Identification of cellular microRNA miR-188-3p with broad-spectrum anti-influenza A virus activity.

Authors:  Huan Cui; Chunmao Zhang; Zongzheng Zhao; Cheng Zhang; Yingying Fu; Jiaming Li; Guanxi Chen; Mengxi Lai; Zhixiang Li; Shishan Dong; Ligong Chen; Zhaoyang Li; Chengyu Wang; Juxiang Liu; Yuwei Gao; Zhendong Guo
Journal:  Virol J       Date:  2020-01-30       Impact factor: 4.099

6.  Gene-Hydrogel Microenvironment Regulates Extracellular Matrix Metabolism Balance in Nucleus Pulposus.

Authors:  Wei Chen; Hao Chen; Dandan Zheng; Hongbo Zhang; Lianfu Deng; Wenguo Cui; Yuhui Zhang; Hélder A Santos; Hongxing Shen
Journal:  Adv Sci (Weinh)       Date:  2019-10-07       Impact factor: 16.806

Review 7.  Preclinical Experimental Applications of miRNA Loaded BMSC Extracellular Vesicles.

Authors:  Zafer Cetin; Eyup I Saygili; Gokhan Görgisen; Emel Sokullu
Journal:  Stem Cell Rev Rep       Date:  2021-01-04       Impact factor: 5.739

Review 8.  miRNA-Mediated Control of B Cell Responses in Immunity and SLE.

Authors:  Stephanie L Schell; Ziaur S M Rahman
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

Review 9.  MicroRNA-Regulated Gene Delivery Systems for Research and Therapeutic Purposes.

Authors:  Bijay Dhungel; Charmaine A Ramlogan-Steel; Jason C Steel
Journal:  Molecules       Date:  2018-06-21       Impact factor: 4.411

Review 10.  From animal models to patients: the role of placental microRNAs, miR-210, miR-126, and miR-148a/152 in preeclampsia.

Authors:  Sonya Frazier; Martin W McBride; Helen Mulvana; Delyth Graham
Journal:  Clin Sci (Lond)       Date:  2020-04-30       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.